Can nitrous oxide be safely administered to a patient who is taking methotrexate?

Avoid Nitrous Oxide in Patients Taking Methotrexate

Nitrous oxide should NOT be administered to patients currently taking methotrexate due to a clinically significant drug interaction that can result in severe, potentially life-threatening toxicity including myelosuppression, stomatitis, and neurotoxicity. 1

Mechanism of Interaction

The interaction between nitrous oxide and methotrexate is pharmacologically well-established and clinically dangerous:

• Both agents inhibit folate-dependent metabolic pathways through different mechanisms. Nitrous oxide irreversibly inactivates methionine synthase (a vitamin B12-dependent enzyme), while methotrexate inhibits dihydrofolate reductase 1, 2

• This dual inhibition creates a synergistic depletion of functional folate, dramatically amplifying methotrexate's toxic effects on rapidly dividing cells (bone marrow, gastrointestinal mucosa, nervous system) 3

• Animal studies demonstrate that nitrous oxide exposure reduces the lethal dose of methotrexate from 60 mg/kg to just 10 mg/kg - a 6-fold increase in toxicity 3

Clinical Evidence of Harm

The FDA drug label explicitly warns against this combination 1. Supporting evidence includes:

• Severe neurotoxicity has been documented in pediatric leukemia patients receiving intrathecal methotrexate with nitrous oxide sedation, with symptoms lasting up to 12 months 4

• Case reports demonstrate stroke-like encephalopathy, seizures, and leukoencephalopathy when these agents are combined 5, 6

• The toxicity manifests as myelosuppression, mucositis, stomatitis, and neurologic complications - all representing exaggerated methotrexate adverse effects 1

Practical Recommendations

For patients on methotrexate requiring anesthesia or sedation:

• Use alternative anesthetic agents - propofol, sevoflurane, or other volatile agents are safe alternatives 5
• Avoid nitrous oxide completely during the methotrexate treatment period
• Exercise caution even after recent nitrous oxide exposure - the FDA label specifically warns about administering methotrexate after recent nitrous oxide use 1

Timing considerations:

• The interaction risk persists as long as methotrexate is being actively administered
• For patients with psoriasis or rheumatoid arthritis on weekly methotrexate dosing (7.5-25 mg/week), nitrous oxide should be avoided throughout the treatment course 7
• The British Association of Dermatologists guidelines support continuing methotrexate perioperatively for dermatologic conditions, but this assumes nitrous oxide is NOT used 8

Common Pitfalls to Avoid

1. Don't assume low-dose methotrexate is safe with nitrous oxide - the interaction occurs at all methotrexate doses, including the lower doses used for rheumatologic and dermatologic conditions 1

2. Don't rely on folate supplementation for protection - while folic acid (1-5 mg daily) is routinely recommended with methotrexate therapy 7, 9, it does NOT adequately protect against the nitrous oxide interaction. Only folinic acid (leucovorin) provides rescue from this specific toxicity 3

3. Don't forget about vitamin B12 status - patients with low B12 levels are at even higher risk, as both nitrous oxide and methotrexate affect B12-dependent pathways 6

The evidence is sufficiently compelling that a precautionary approach is mandatory: select alternative anesthetic agents and completely avoid nitrous oxide in any patient receiving methotrexate therapy 5.